Verweij, P E <br/><br/>
Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients.  [electronic resource] 

 -  Infection   
 - 81-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0300-8126 
<br/><br/><label>Standard No.: </label>10.1007/BF01739009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amphotericin B--therapeutic use<br/>Creatinine--blood<br/>Drug Therapy, Combination<br/>Female<br/>Flucytosine--therapeutic use<br/>Granulocytes<br/>Humans<br/>Infusions, Intravenous<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Mycoses--diagnosis<br/>Neutropenia--blood<br/>Neutrophils<br/>Prognosis<br/>Survival Rate<br/>Treatment Failure